View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAlbioma 配当と自社株買い配当金 基準チェック /36主要情報1.8%配当利回り0.1%バイバック利回り総株主利回り1.9%将来の配当利回り2.2%配当成長7.2%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向47%最近の配当と自社株買いの更新Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 18% share price gain to €45.60, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 139% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €30.87 per share.Reported Earnings • Mar 03Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.88 (up from €1.78 in FY 2020). Revenue: €573.3m (up 13% from FY 2020). Net income: €59.0m (up 6.7% from FY 2020). Profit margin: 10% (in line with FY 2020). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 1.6%, compared to a 14% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to €40.86, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 130% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.96 per share.分析記事 • Feb 27Returns On Capital At Albioma (EPA:ABIO) Have StalledIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...分析記事 • Nov 23Albioma (EPA:ABIO) Has More To Do To Multiply In Value Going ForwardThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...分析記事 • Oct 18Is Albioma (EPA:ABIO) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • Aug 19Albioma's (EPA:ABIO) Returns Have Hit A WallIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Reported Earnings • Jul 30First half 2021 earnings released: EPS €0.75 (vs €0.79 in 1H 2020)The company reported a mediocre first half result with weaker earnings, although profit margins were flat and revenues improved. First half 2021 results: Revenue: €267.7m (up 6.8% from 1H 2020). Net income: €23.5m (down 3.5% from 1H 2020). Profit margin: 8.8% (in line with 1H 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).分析記事 • May 12Albioma's (EPA:ABIO) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...分析記事 • Apr 28Is Albioma (EPA:ABIO) Worth €39.2 Based On Its Intrinsic Value?Does the April share price for Albioma ( EPA:ABIO ) reflect what it's really worth? Today, we will estimate the stock's...分析記事 • Mar 25These 4 Measures Indicate That Albioma (EPA:ABIO) Is Using Debt ExtensivelyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...分析記事 • Mar 07Is Albioma (EPA:ABIO) A High Quality Stock To Own?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...Reported Earnings • Mar 06Full year 2020 earnings released: EPS €1.78 (vs €1.44 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: €506.7m (flat on FY 2019). Net income: €55.3m (up 25% from FY 2019). Profit margin: 11% (up from 8.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.Analyst Estimate Surprise Post Earnings • Mar 06Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 12%. Over the next year, revenue is forecast to grow 4.3%, compared to a 42% growth forecast for the Renewable Energy industry in France.Price Target Changed • Mar 05Price target raised to €50.86Up from €47.43, the current price target is an average from 7 analysts. The new target price is 27% above the current share price of €40.00. As of last close, the stock is up 12% over the past year.Is New 90 Day High Low • Feb 25New 90-day low: €40.50The company is down 2.0% from its price of €41.35 on 26 November 2020. The French market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.48 per share.分析記事 • Feb 18Albioma (EPA:ABIO) Has Rewarded Shareholders With An Exceptional 332% Total Return On Their InvestmentWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...分析記事 • Jan 23Is Albioma (EPA:ABIO) Likely To Turn Things Around?If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • Jan 05What Kind Of Shareholders Own Albioma (EPA:ABIO)?Every investor in Albioma ( EPA:ABIO ) should be aware of the most powerful shareholder groups. Generally speaking, as...Is New 90 Day High Low • Jan 04New 90-day high: €47.90The company is up 6.0% from its price of €45.10 on 06 October 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €20.68 per share.分析記事 • Dec 19At €43.80, Is It Time To Put Albioma (EPA:ABIO) On Your Watch List?Albioma ( EPA:ABIO ), is not the largest company out there, but it saw a decent share price growth in the teens level...分析記事 • Dec 06A Closer Look At Albioma's (EPA:ABIO) Impressive ROEOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...分析記事 • Nov 22How Is Albioma's (EPA:ABIO) CEO Paid Relative To Peers?This article will reflect on the compensation paid to Frédéric Moyne who has served as CEO of Albioma (EPA:ABIO) since...Price Target Changed • Oct 30Price target raised to €45.63Up from €41.20, the current price target is an average from 7 analysts. The new target price is 14% above the current share price of €39.95. As of last close, the stock is up 71% over the past year.Is New 90 Day High Low • Oct 08New 90-day high: €45.65The company is up 16% from its price of €39.35 on 09 July 2020. The French market is flat over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Renewable Energy industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €19.25 per share.決済の安定と成長配当データの取得安定した配当: ABIOの1株当たり配当金は過去10年間安定しています。増加する配当: ABIOの配当金は過去10年間にわたって増加しています。配当利回り対市場Albioma 配当利回り対市場ABIO 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (ABIO)1.8%市場下位25% (FR)2.0%市場トップ25% (FR)5.7%業界平均 (Renewable Energy)2.2%アナリスト予想 (ABIO) (最長3年)2.2%注目すべき配当: ABIOの配当金 ( 1.78% ) はFrench市場の配当金支払者の下位 25% ( 1.99% ) と比べると目立ったものではありません。高配当: ABIOの配当金 ( 1.78% ) はFrench市場の配当金支払者の上位 25% ( 5.67% ) と比較すると低いです。株主への利益配当収益カバレッジ: ABIOの 配当性向 ( 47.1% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: ABIOは配当金を支払っていますが、同社にはフリーキャッシュフローがありません。高配当企業の発掘7D1Y7D1Y7D1YFR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2022/10/13 04:02終値2022/09/13 00:00収益2022/06/30年間収益2021/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Albioma 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Yohann TerryBNP ParibasCaroline CohenBofA Global ResearchEmmanuel ChevalierCIC Market Solutions (ESN)10 その他のアナリストを表示
Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 18% share price gain to €45.60, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 139% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €30.87 per share.
Reported Earnings • Mar 03Full year 2021 earnings: EPS and revenues exceed analyst expectationsFull year 2021 results: EPS: €1.88 (up from €1.78 in FY 2020). Revenue: €573.3m (up 13% from FY 2020). Net income: €59.0m (up 6.7% from FY 2020). Profit margin: 10% (in line with FY 2020). Revenue exceeded analyst estimates by 2.9%. Earnings per share (EPS) also surpassed analyst estimates by 3.1%. Over the next year, revenue is forecast to grow 1.6%, compared to a 14% growth forecast for the industry in France. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to €40.86, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 25x in the Renewable Energy industry in Europe. Total returns to shareholders of 130% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €24.96 per share.
分析記事 • Feb 27Returns On Capital At Albioma (EPA:ABIO) Have StalledIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
分析記事 • Nov 23Albioma (EPA:ABIO) Has More To Do To Multiply In Value Going ForwardThere are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
分析記事 • Oct 18Is Albioma (EPA:ABIO) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Aug 19Albioma's (EPA:ABIO) Returns Have Hit A WallIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Reported Earnings • Jul 30First half 2021 earnings released: EPS €0.75 (vs €0.79 in 1H 2020)The company reported a mediocre first half result with weaker earnings, although profit margins were flat and revenues improved. First half 2021 results: Revenue: €267.7m (up 6.8% from 1H 2020). Net income: €23.5m (down 3.5% from 1H 2020). Profit margin: 8.8% (in line with 1H 2020). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 22% per year, which means it is tracking significantly ahead of earnings growth.
Upcoming Dividend • Jun 03Upcoming dividend of €0.80 per shareEligible shareholders must have bought the stock before 10 June 2021. Payment date: 09 July 2021. Trailing yield: 2.3%. Lower than top quartile of French dividend payers (3.8%). In line with average of industry peers (2.4%).
分析記事 • May 12Albioma's (EPA:ABIO) Returns Have Hit A WallIf you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
分析記事 • Apr 28Is Albioma (EPA:ABIO) Worth €39.2 Based On Its Intrinsic Value?Does the April share price for Albioma ( EPA:ABIO ) reflect what it's really worth? Today, we will estimate the stock's...
分析記事 • Mar 25These 4 Measures Indicate That Albioma (EPA:ABIO) Is Using Debt ExtensivelyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
分析記事 • Mar 07Is Albioma (EPA:ABIO) A High Quality Stock To Own?One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Reported Earnings • Mar 06Full year 2020 earnings released: EPS €1.78 (vs €1.44 in FY 2019)The company reported a solid full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: €506.7m (flat on FY 2019). Net income: €55.3m (up 25% from FY 2019). Profit margin: 11% (up from 8.7% in FY 2019). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 23% per year, which means it is tracking significantly ahead of earnings growth.
Analyst Estimate Surprise Post Earnings • Mar 06Earnings beat expectations, revenue disappointsRevenue missed analyst estimates by 3.1%. Earnings per share (EPS) exceeded analyst estimates by 12%. Over the next year, revenue is forecast to grow 4.3%, compared to a 42% growth forecast for the Renewable Energy industry in France.
Price Target Changed • Mar 05Price target raised to €50.86Up from €47.43, the current price target is an average from 7 analysts. The new target price is 27% above the current share price of €40.00. As of last close, the stock is up 12% over the past year.
Is New 90 Day High Low • Feb 25New 90-day low: €40.50The company is down 2.0% from its price of €41.35 on 26 November 2020. The French market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.48 per share.
分析記事 • Feb 18Albioma (EPA:ABIO) Has Rewarded Shareholders With An Exceptional 332% Total Return On Their InvestmentWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...
分析記事 • Jan 23Is Albioma (EPA:ABIO) Likely To Turn Things Around?If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
分析記事 • Jan 05What Kind Of Shareholders Own Albioma (EPA:ABIO)?Every investor in Albioma ( EPA:ABIO ) should be aware of the most powerful shareholder groups. Generally speaking, as...
Is New 90 Day High Low • Jan 04New 90-day high: €47.90The company is up 6.0% from its price of €45.10 on 06 October 2020. The French market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Renewable Energy industry, which is up 26% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €20.68 per share.
分析記事 • Dec 19At €43.80, Is It Time To Put Albioma (EPA:ABIO) On Your Watch List?Albioma ( EPA:ABIO ), is not the largest company out there, but it saw a decent share price growth in the teens level...
分析記事 • Dec 06A Closer Look At Albioma's (EPA:ABIO) Impressive ROEOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
分析記事 • Nov 22How Is Albioma's (EPA:ABIO) CEO Paid Relative To Peers?This article will reflect on the compensation paid to Frédéric Moyne who has served as CEO of Albioma (EPA:ABIO) since...
Price Target Changed • Oct 30Price target raised to €45.63Up from €41.20, the current price target is an average from 7 analysts. The new target price is 14% above the current share price of €39.95. As of last close, the stock is up 71% over the past year.
Is New 90 Day High Low • Oct 08New 90-day high: €45.65The company is up 16% from its price of €39.35 on 09 July 2020. The French market is flat over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Renewable Energy industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €19.25 per share.